Mix and match - A comprehensive pipeline for matched patient-derived PDX and PD3D® modelsfor cancer research and preclinical drug development

被引:1
|
作者
Loskutov, Jurgen
Oswald, Eva
Reinhard, Christoph J.
Schueler, Julia
Regenbrecht, Christian R.
机构
关键词
D O I
10.1158/1538-7445.AM2024-240
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
240
引用
收藏
页数:2
相关论文
共 50 条
  • [22] Development of Patient-Derived 3D Tumor Organoids Combined with Immune Cells, as Preclinical Testing Platform for Personalized Cancer Immunotherapy
    Antignani, Gabriella
    Feola, Sara
    Ferrari, Valentina
    Ciampi, Daniele
    Chiaro, Jacopo
    Feodoroff, Michaela
    Fusciello, Manlio
    Russo, Salvatore
    Hissaoui, Firas Hamdan
    Molsa, Riikka
    Haapala, Markus
    Gronholm, Mikaela
    Branca, Rui Mamede
    Rescigno, Maria
    Sikanen, Tiina
    Lehtio, Janne
    Cerullo, Vincenzo
    MOLECULAR THERAPY, 2023, 31 (04) : 658 - 659
  • [23] Establishment of patient-derived xenografts (PDX) models for triple negative breast cancer (TNBC) as a pre-clinical platform for drug development
    Thatte, J.
    Meza, M.
    Ricono, J.
    Broudy, T.
    Mirsaidi, C.
    Nair, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 50 - 50
  • [24] A Review on Patient-derived 3D Micro Cancer Approach for Drug Screen in Personalized Cancer Medicine
    Sekeroglu, Zuelal Atli
    Sekeroglu, Vedat
    CURRENT CANCER DRUG TARGETS, 2025, 25 (02) : 118 - 130
  • [25] Development of automated 3D high-throughput drug screening platform for patient-derived breast cancer organoids
    Kim, Jungeun
    Kim, Hoe Suk
    Kim, Ga Yeon
    Park, Kyung Hyeun
    Ryu, Seung Yeon
    Lee, Sangeun
    Lee, Dong Woo
    Ku, Bosung
    Lee, Han-Byoel
    Han, Wonshik
    CANCER RESEARCH, 2022, 82 (04)
  • [26] Precision cancer medicine based on 3D drug profiling of patient-derived cancer cell spheroid models
    Mikkonen, Piia
    Turunen, Laura
    Paasonen, Lauri
    Potdar, Swapnil
    Paavolainen, Lassi
    Murumagi, Astrid
    Kallioniemi, Olli
    Pietiainen, Vilja M.
    CANCER RESEARCH, 2018, 78 (13)
  • [27] Molecular profiling and characterization of patient-derived human pancreatic tumor xenograft models, and application for drug discovery and preclinical development of cancer therapeutics
    Mattie, Michael D.
    Chang, Mi Sook
    Christensen, Ashley
    Yeh, William
    Said, Suzanne
    Shostak, Yuriy
    Capo, Linnette
    Verlinsky, Alla
    An, Zili
    Kumar-Ganesan, Sathish
    Morrison, Karen
    Joseph, Ingrid
    Stover, David
    Challita-Eid, Pia
    CANCER RESEARCH, 2012, 72
  • [28] Patient-derived 3D tumor cultures for clinical diagnostics and pre-clinical drug development
    Dijkmans, Thomas
    Basten, Sander
    Herpers, Bram
    Yan, Kuan
    Giesemann, Torsten
    Schueler, Julia
    Vader, Willemijn
    Price, Leo
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Patient-derived 3D tumor cultures for compound screening and pre-clinical drug development
    Basten, Sander
    Herpers, Bram
    Yan, Kuan
    Schueler, Julia
    Price, Leo S.
    CANCER RESEARCH, 2019, 79 (13)
  • [30] Combination therapies in matched 3D in vitro and in vivo preclinical models of rare and recalcitrant cancers from the National Cancer Institute's Patient-Derived Models Repository
    Dexheimer, Thomas S.
    Silvers, Thomas
    Delosh, Rene
    Reinhart, Russell
    Ogle, Chad
    Davoudi, Zahra
    Jones, Eric
    Trail, Debbie
    Carter, John
    Mills, Justine
    Georgius, Kyle
    Stotler, Howard
    Norris, Michelle
    Uzelac, Shannon
    Borgel, Suzanne
    Minor, Tiffanie
    Stockwin, Luke
    Mullendore, Michael
    Plater, Kevin
    Kalmbach, Keegan
    Steed, Jessica
    Murphy, Matthew
    Bliss, Gareth
    Bonomi, Carrie
    Dougherty, Kelly
    Gibson, Marion
    Cooper, Kevin
    Newton, Dianne
    Timme, Cindy R.
    Evrard, Yvonne A.
    Hollingshead, Melinda G.
    Coussens, Nathan P.
    Parchment, Ralph E.
    Doroshow, James H.
    Teicher, Beverly A.
    CANCER RESEARCH, 2023, 83 (07)